| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 29,398 | 30,521 | 31,403 | | Cost of Revenue | 10,582 | 10,750 | 11,275 | | | Gross Profit | 18,817 | 19,771 | 20,129 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 15,853 | 16,215 | 16,630 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,964 | 3,555 | 3,499 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 175 | 177 | 387 | | Earnings Before Interest And Taxes | 3,139 | 3,732 | 3,886 | | Interest Expense |
-
|
-
| 8 | | Income Before Tax | 3,139 | 3,732 | 3,878 | | Income Tax Expense | 1,226 | 1,408 | 1,471 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,913 | 2,324 | 2,407 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,913 | 2,324 | 2,407 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,913 | $2,324 | $2,407 |
|
0.83% Nasdaq 0.00%
Income Statement
